Data processing application method of bacteriophage specific antibacterial peptide
By collecting and analyzing phage polypeptide data and antibacterial peptide data from public databases, building data sets and using neural networks for classification prediction, the problem of unexplored synergy between phage and antibacterial peptides in the existing technology has been solved, and phage specificity has been achieved The accurate classification of sexual antibacterial peptides improves the efficiency of joint application.
Patent Information
- Application Number
- CN202411105076.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-08-13
AI Technical Summary
The prior art lacks in-depth exploration of the synergistic effects of phages and antibacterial peptides, and lacks exploration of gene fragments encoding antibacterial peptides in the phage genome, resulting in time-consuming and labor-intensive experiments.
By collecting phage polypeptide data and antibacterial peptide data from public databases, homology analysis and preprocessing, constructing positive and negative sample data sets, using neural networks for classification prediction, and achieving phage-specific antibacterial peptides or non- Accurate classification of antibacterial peptides.
Achieved in-depth exploration of the synergistic effects of phages and antibacterial peptides, improved the efficiency of the combined application of phages and antibacterial peptides, provided accurate target classification results, and contributed to the subsequent improvement of phage engineering and the discovery of efficient antibacterial peptides. .
Smart Images

Figure CN118918944A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of collaborative processing of bacteriophage data and antibacterial peptide data, and in particular to an application method for processing bacteriophage-specific antibacterial peptide data. Background Art
[0002] The misuse of antibiotics will not only lead to bacterial resistance, but also cause the disorder of normal flora in the human body, which poses a great threat to human life. Bacteriophages grow and reproduce in host cells, which can cause the lysis of pathogenic bacteria, reduce the density of pathogenic bacteria, and reduce or avoid the chance of infection or disease caused by pathogens. Antibacterial peptides (ABPs) are an element of the innate immunity of organisms, which have broad-spectrum bacterial activity. Bacteriophages and antibacterial peptides have become effective alternatives to antibiotics with a completely different bactericidal mechanism from antibiotics and very few side effects.
[0003] Although some studies have proposed that antibacterial peptides can be used to enhance phages, and phage-driven antibacterial peptide expression systems have been verified based on experiments, very few studies have explored the synergistic effects of the two, and there is also a lack of research on the gene fragments encoding antibacterial peptides in the phage genome, making laboratory methods time-consuming and labor-intensive.
[0004] In order to solve the above problems, it is necessary to propose a convenient and efficient data mining method to conduct in-depth exploration of the synergistic effects of bacteriophages and antibacterial peptides and improve the combined application of bacteriophages and antibacterial peptides. Summary of the invention
[0005] In view of the above problems, the purpose of the present invention is to provide a phage-specific antibacterial peptide data processing application method, to conduct in-depth exploration of the synergistic effect of phage and antibacterial peptides, and to improve the combined application of phage and antibacterial peptides.
[0006] The embodiment of the present invention provides a bacteriophage-specific antibacterial peptide data processing application method, comprising:
[0007] S1. Collect phage peptide data from public databases;
[0008] S2. Collect antibacterial peptide data and non-antibacterial peptide data from public databases;
[0009] S3, after removing redundant sequences from the antibacterial peptide data and non-antibacterial peptide data, homology analysis is performed with the phage peptide data, and after preprocessing, phage-specific antibacterial peptide data and non-antibacterial peptide data are obtained;
[0010] S4. Use phage-specific antibacterial peptide data and non-antibacterial peptide data to construct positive sample data sets and negative sample data sets;
[0011] S5. Train a neural network based on the positive sample data set and the negative sample data set, apply the neural network, and obtain positive and negative sample classification predictions of bacteriophage-specific antibacterial peptides or non-antibacterial peptide data.
[0012] Furthermore, the process of collecting phage polypeptide data in S1 includes:
[0013] S11. Collect phage genome sequences from public databases;
[0014] S12, use PHANOTATE tool to identify small open reading frame sequences in phage genome sequences;
[0015] S13. Use the BioPython library to transcribe and translate the small open reading frame sequences found to obtain phage polypeptide data.
[0016] Further, in said S13:
[0017] The transcription process includes: synthesizing an expected complementary mRNA coding chain using the phage DNA chain as a template, performing transcription operations on each small open reading frame sequence, and obtaining mRNA coding information;
[0018] The translation process includes: translating the mRNA coding information formed after transcription into the corresponding amino acid sequence according to the codons in the codon table to obtain the phage polypeptide data.
[0019] Further, in said S2:
[0020] The process of collecting antibacterial peptide data includes:
[0021] S2A1, collect peptide sequences with antibacterial activity from the CAMPR4 database;
[0022] S2A2, retaining the experimentally verified polypeptide sequences with antibacterial activity;
[0023] S2A3. Use the CD-HIT tool to remove redundant sequences with a similarity of 90% and sequences with a length of less than 5 amino acids in the peptide sequence data to obtain antibacterial peptide data.
[0024] The process of collecting data on non-antibacterial peptides included:
[0025] S2B1, collect peptide sequences with non-antibacterial activity from the UniProt database;
[0026] S2B2. Use the CD-HIT tool to remove redundant sequences in peptide sequences with non-antibacterial activity and sequences with a length of less than 5 amino acids to obtain non-antibacterial peptide data.
[0027] Furthermore, the process of obtaining the bacteriophage-specific antibacterial peptide data and non-antibacterial peptide data in S3 includes:
[0028] S31, using the BLASTp tool to compare the phage polypeptide data with the antibacterial peptide data and the non-antibacterial peptide data, respectively, to obtain preliminary sequences of the phage-specific antibacterial peptides and non-antibacterial peptides;
[0029] S32. Remove repetitive sequences from the preliminary sequences of antibacterial peptides and non-antibacterial peptides, remove sequences longer than 100 amino acids, and remove sequences containing non-natural amino acids to obtain phage-specific antibacterial peptide and non-antibacterial peptide data.
[0030] Furthermore, the positive sample data set and the negative sample data set in S4 are respectively divided into a training set, a validation set and a test set by a stratified sampling strategy.
[0031] Furthermore, the neural network application in S5 comprises the steps of:
[0032] S51, using the ESM-2 protein pre-training model to convert the amino acid letter representations in the phage-specific antibacterial peptide and non-antibacterial peptide sequences into embedded feature representations in space;
[0033] S52, performing a convolution operation on the embedded features using a convolutional neural network (CNN) with a feature extraction function;
[0034] S53. The convolutional feature representation is input into the fully connected layer (FCN) to perform positive and negative sample classification prediction on the bacteriophage-specific antibacterial peptide or non-bacteriophage-specific antibacterial peptide.
[0035] Beneficial effects of the present invention:
[0036] 1. The present invention utilizes public databases and proposes an effective data collection method to collect phage polypeptide data, antibacterial peptide data and non-antibacterial peptide data. It combines bioinformatics analysis tools to analyze and find important gene coding fragments, explore the synergistic effect between phages and antibacterial peptides, and achieve accurate target classification of phage-specific antibacterial peptides / non-phage-specific antibacterial peptides, thereby contributing to the subsequent engineering improvement of phages and the discovery of potential highly effective antibacterial peptides.
[0037] 2. The present invention utilizes phage-specific antibacterial peptide data and non-antibacterial peptide data to construct positive sample data sets and negative sample data sets, conducts neural network training and application, obtains positive and negative sample classification predictions of phage-specific antibacterial peptide or non-antibacterial peptide data, and verifies the accuracy of phage-specific antibacterial peptide / non-phage-specific antibacterial peptide target classification. BRIEF DESCRIPTION OF THE DRAWINGS
[0038] Figure 1 The figure is a flow chart of the application method of the bacteriophage-specific antibacterial peptide data processing of the present invention;
[0039] Figure 2 It is a schematic diagram of the principle structure of the present invention;
[0040] Figure 3 It is a schematic diagram of the neural network training application process of the present invention. DETAILED DESCRIPTION
[0041] Embodiments of the present invention are described in detail below, examples of which are shown in the accompanying drawings, wherein the same or similar symbols throughout represent the same or similar elements or elements with the same or similar functions. The embodiments described below with reference to the accompanying drawings are exemplary and are only used to explain the present invention, and cannot be understood as limiting the present invention.
[0042] In the prior art, there is a lack of exploration into the synergistic effects of bacteriophages and antibacterial peptides, and there is also a lack of exploration into the gene fragments encoding antibacterial peptides in the bacteriophage genome.
[0043] In view of the above problems, the present invention provides a bacteriophage-specific antibacterial peptide data processing application method. Figure 1 A schematic flow chart of a phage-specific antibacterial peptide data processing application method provided in an embodiment of the present invention, the method comprising:
[0044] S1. Collect phage peptide data from public databases.
[0045] like Figure 2 As shown, the public database can be used to collect the genome sequence of bacteriophages in the public database of the National Center for Bioinformation (NCBI) of the United States; then, the PHANOTATE tool is used to identify small open reading frames in the phage genome sequence, which have the potential to encode polypeptides; finally, the BioPython toolkit is used to perform two steps of transcription and translation on the found small open reading frame sequences, and finally the polypeptide sequence data of the phage is obtained.
[0046] The transcription process includes: using the phage DNA chain as a template to synthesize an expected complementary mRNA coding chain, performing transcription operations on each small open reading frame sequence, obtaining mRNA coding information, and ensuring accurate transmission of information.
[0047] The translation process includes: translating the mRNA coding information formed after transcription into the corresponding amino acid sequence according to the codons in the codon table to obtain the phage polypeptide data.
[0048] After the two steps of transcription and translation, the coding information in the phage DNA chain is converted into polypeptide sequence information.
[0049] S2. Collect antibacterial peptide data and non-antibacterial peptide data from public databases.
[0050] For the collection of antibacterial peptide data, peptide sequences with antibacterial activity can be collected from the CAMPR4 database, and only experimentally verified antibacterial peptides are retained. Then, the CD-HIT tool is used to remove redundant sequences with a similarity of 90% and sequences with a length of less than 5 amino acids in the data to obtain antibacterial peptide data.
[0051] For the collection of non-antibacterial peptide data, since there is currently no experimentally verified non-antibacterial peptide data available in public databases, polypeptide sequences with non-antibacterial activity can be collected from the Universal Protein Resource Database (UniProt) database; analogous to the antibacterial peptide data collection and processing method, the CD-HIT tool is used to remove redundant sequences in polypeptide sequences with non-antibacterial activity, as well as sequences with a length of less than 5 amino acids, to obtain non-antibacterial peptide data.
[0052] S3. Analyze the phage peptide data, the antibacterial peptide data and the non-antibacterial peptide data respectively, and obtain the phage-specific antibacterial peptide data and the non-antibacterial peptide data after preprocessing.
[0053] Previous studies have shown that antibacterial peptides can be used to enhance bacteriophages, and that antibacterial peptides may be derived from the genome sequence of bacteriophage hemolysin. Therefore, as important bacteriophage elements, antibacterial peptides can effectively modify the corresponding phage genome sequence, thereby improving the bacteriophage's sterilization ability.
[0054] The homology of the bacteriophage and the antibacterial peptide can be determined by performing similarity analysis on them, and the homology columns can be compared using the BLASTp tool (for example, setting the query coverage percentage to 50 and the expected alignment value to the default value of 10) to obtain the preliminary sequence of the bacteriophage-specific antibacterial peptide.
[0055] The phage and non-antibacterial peptides can be analyzed for similarity to determine their homology, or the BLASTp tool can be used for similarity comparison to obtain the preliminary sequence of the phage-specific non-antibacterial peptide.
[0056] like Figure 2As shown, the phage-specific antibacterial peptide data and non-antibacterial peptide data after sequence alignment are preprocessed. When illegal data appears, the data quality will be reduced, so the data needs to be screened out. Peptide sequences that are too long have weak antibacterial activity and may be toxic, so it is necessary to remove them. Non-natural amino acids usually do not represent important biological information and may also introduce interference factors, so they are removed in order to better understand the biological processes in natural organisms. To address the above problems, the processing steps include removing repeated sequences, removing sequences longer than 100 amino acids, and removing sequences containing non-natural amino acids, so as to obtain high-quality phage-specific antibacterial peptide and non-antibacterial peptide data.
[0057] S4. Use phage-specific antibacterial peptide data and non-antibacterial peptide data to construct positive sample data sets and negative sample data sets.
[0058] After obtaining the phage-specific antibacterial peptide and non-antibacterial peptide data, in order to better verify the accuracy of the acquisition of the phage-specific antibacterial peptide, a neural network can be used to accurately classify the phage-specific antibacterial peptide or the non-phage-specific antibacterial peptide.
[0059] The positive sample data set and the negative sample data set were constructed using the phage-specific antibacterial peptide data and the non-antibacterial peptide data. The positive sample data set and the negative sample data set were divided into the data sets by a stratified sampling strategy, and the proportions of the training set, validation set and test set of each category were approximately equal.
[0060] S5. Train a neural network based on the positive sample data set and the negative sample data set, apply the neural network, and obtain positive and negative sample classification predictions of bacteriophage-specific antibacterial peptides or non-antibacterial peptide data.
[0061] The neural network is trained, verified and tested based on the training set, validation set and test set obtained from the positive sample data and the negative sample data to obtain a trained neural network.
[0062] Use the trained neural network to perform neural network applications, such as Figure 3 As shown, including:
[0063] Feature extraction,The protein universal pre-trained model (ESM-2) is applied to the amino acid representation of,the phage-specific antibacterial peptide data to generate an,embedded feature vector representation in space.
[0064] Feature processing: A convolutional neural network (CNN) with feature extraction function performs convolution operation on the embedded features to achieve feature extraction of antibacterial peptide data.
[0065] Target classification, a fully connected neural network (FCN) with classification function is used as a classifier to perform target classification of phage-specific antibacterial peptides / non-antibacterial peptides.
[0066] Experimental data:
[0067] This experiment uses a data set of phage-specific antibacterial peptides or non-antibacterial peptides obtained after collection, processing and analysis. The data set contains 655 phage-specific antibacterial peptides and 2959 phage-specific non-antibacterial peptides.
[0068] 80% of each dataset is used as training set and 20% as testing set.
[0069] The evaluation index is accuracy (ACC Accuracy), and the calculation formula is:
[0070]
[0071] Among them, TP (True Positive) represents the number of true positives, that is, the number of true phage-specific antibacterial peptide sequences correctly predicted, TN (True Negative) represents the number of true negatives, that is, the number of true phage-specific non-antibacterial peptide sequences correctly predicted, FP (False Positive) is the number of false positives, that is, the number of phage-specific antibacterial peptide sequences that were originally phage-specific antibacterial peptide sequences but were predicted to be phage-specific non-antibacterial peptide sequences, and FN (False Negative) is the number of false negatives, that is, the number of phage-specific non-antibacterial peptide sequences that were originally phage-specific antibacterial peptide sequences but were predicted to be phage-specific antibacterial peptides.
[0072] Table 1. Experimental results of data set model application
[0073]
[0074] As shown in Table 1, Table 1 shows the prediction results on the test set (including 132 positive samples and 592 negative samples) under this evaluation index. Using five-fold cross validation on the training set, the average accuracy index on the validation set is 98%±1%, and the accuracy index on the test set reaches 98.5%.
[0075] From the results in the table, it can be found that this method can provide accurate and real data samples, and can accurately reflect the diversity and complexity of bacteriophages and antibacterial peptides.
[0076] The present invention adopts the above method to collect phage polypeptide data and antibacterial peptide data and non-antibacterial peptide data from a public database; analyze and pre-process the phage polypeptide data and the antibacterial peptide data and the non-antibacterial peptide data respectively to obtain phage-specific antibacterial peptide data and non-antibacterial peptide data. Then, the phage-specific antibacterial peptide data and the non-antibacterial peptide data are used to construct positive sample data sets and negative sample data sets, and a neural network is applied to obtain positive and negative sample classification predictions of phage-specific antibacterial peptide or non-antibacterial peptide data, and verify the accuracy of phage-specific antibacterial peptide or non-antibacterial peptide data.
[0077] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or make equivalent replacements for some of the technical features therein. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
Claims
1. A bacteriophage-specific antibacterial peptide data processing application method, characterized in that: include: S1. Collect phage peptide data from public databases; S2. Collect antibacterial peptide data and non-antibacterial peptide data from public databases; S3, after removing redundant sequences from the antibacterial peptide data and non-antibacterial peptide data, homology analysis is performed with the phage peptide data, and after preprocessing, phage-specific antibacterial peptide data and non-antibacterial peptide data are obtained; S4. Use phage-specific antibacterial peptide data and non-antibacterial peptide data to construct positive sample data sets and negative sample data sets; S5. Train a neural network based on the positive sample data set and the negative sample data set, apply the neural network, and obtain positive and negative sample classification predictions of bacteriophage-specific antibacterial peptides or non-antibacterial peptide data.
2. The method for processing and applying bacteriophage-specific antibacterial peptide data according to claim 1, characterized in that: The process of collecting phage polypeptide data in S1 includes: S11. Collect phage genome sequences from public databases; S12, use PHANOTATE tool to identify small open reading frame sequences in phage genome sequences; S13. Use the BioPython library to transcribe and translate the small open reading frame sequences found to obtain phage polypeptide data.
3. The method for processing and applying bacteriophage-specific antibacterial peptide data according to claim 2, characterized in that: In S13: The transcription process includes: synthesizing an expected complementary mRNA coding chain using the phage DNA chain as a template, performing transcription operations on each small open reading frame sequence, and obtaining mRNA coding information; The translation process includes: translating the mRNA coding information formed after transcription into the corresponding amino acid sequence according to the codons in the codon table to obtain the phage polypeptide data.
4. The method for processing and applying bacteriophage-specific antibacterial peptide data according to claim 1, characterized in that: In S2: The process of collecting antibacterial peptide data includes: S2A1, collect peptide sequences with antibacterial activity from the CAMPR4 database; S2A2, retaining the experimentally verified polypeptide sequences with antibacterial activity; S2A3, using CD-HIT tool to remove redundant sequences with a similarity of 90% and sequences with a length of less than 5 amino acids in the peptide sequence data to obtain antibacterial peptide data; The process of collecting data on non-antibacterial peptides included: S2B1, collect peptide sequences with non-antibacterial activity from the UniProt database; S2B2. Use the CD-HIT tool to remove redundant sequences in peptide sequences with non-antibacterial activity and sequences with a length of less than 5 amino acids to obtain non-antibacterial peptide data.
5. The method for processing and applying bacteriophage-specific antibacterial peptide data according to claim 4, characterized in that: The process of obtaining phage-specific antibacterial peptide data and non-antibacterial peptide data in S3 includes: S31, using the BLASTp tool to compare the phage polypeptide data with the antibacterial peptide data and the non-antibacterial peptide data, respectively, to obtain preliminary sequences of the phage-specific antibacterial peptides and non-antibacterial peptides; S32. Remove repetitive sequences from the preliminary sequences of antibacterial peptides and non-antibacterial peptides, remove sequences longer than 100 amino acids, and remove sequences containing non-natural amino acids to obtain phage-specific antibacterial peptide and non-antibacterial peptide data.
6. The method for processing and applying bacteriophage-specific antibacterial peptide data according to claim 1, characterized in that: The positive sample data set and the negative sample data set in S4 are respectively divided into a training set, a validation set and a test set by a stratified sampling strategy.
7. The method for processing and applying bacteriophage-specific antibacterial peptide data according to claim 1, characterized in that: The neural network application in S5 comprises the steps of: S51, using the ESM-2 protein pre-training model to convert the letter form representation in the phage-specific antibacterial peptide and non-antibacterial peptide sequences into embedded feature representations in space; S52, performing a convolution operation on the embedded features using a convolutional neural network (CNN) with a feature extraction function; S53. The convolutional feature representation is input into the fully connected layer (FCN) to perform positive and negative sample classification prediction on the bacteriophage-specific antibacterial peptide or non-bacteriophage-specific antibacterial peptide.
Citation Information
Patent Citations
Low-cost high throughput screening method of antibacterial peptide lead compound
CN103590116A
Methods to determine sensitivity profile of bacterial strain to therapeutic composition
CN111052248A
Method for mining and generating high-effect antibacterial peptide at high throughput through large language model
CN118116473A
Acquisition method of antibacterial peptide discriminator
CN118412042A
Methods and compositions for sequence specific antimicrobials
US20180273937A1
